0000899243-16-036028.txt : 20161220 0000899243-16-036028.hdr.sgml : 20161220 20161220160535 ACCESSION NUMBER: 0000899243-16-036028 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20161216 FILED AS OF DATE: 20161220 DATE AS OF CHANGE: 20161220 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Coherus BioSciences, Inc. CENTRAL INDEX KEY: 0001512762 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 273615821 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: C/O DENNIS M. LANFEAR STREET 2: 333 TWIN DOLPHIN DR, SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 BUSINESS PHONE: (650) 649-3530 MAIL ADDRESS: STREET 1: C/O DENNIS M. LANFEAR STREET 2: 333 TWIN DOLPHIN DR, SUITE 600 CITY: REDWOOD CITY STATE: CA ZIP: 94065 FORMER COMPANY: FORMER CONFORMED NAME: BioGenerics, Inc. DATE OF NAME CHANGE: 20110210 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Viret Jean-Frederic CENTRAL INDEX KEY: 0001427569 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36721 FILM NUMBER: 162061483 MAIL ADDRESS: STREET 1: ANESIVA, INC. STREET 2: 650 GATEWAY BLVD. CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-12-16 0 0001512762 Coherus BioSciences, Inc. CHRS 0001427569 Viret Jean-Frederic COHERUS BIOSCIENCES, INC. 333 TWIN DOLPHIN DRIVE, SUITE 600 REDWOOD CITY CA 94065 0 1 0 0 Chief Financial Officer Common Stock, $0.0001 par value 2016-12-16 4 M 0 3900 13.50 A 6225 D Common Stock, $0.0001 par value 2016-12-16 4 S 0 3900 28.2987 D 2325 D Common Stock, $0.0001 par value 2016-12-19 4 M 0 667 13.50 A 2992 D Stock Option (right to buy) 13.50 2016-12-16 4 M 0 3900 0.00 D 2024-11-05 Common Stock 3900 117048 D Stock Option (right to buy) 13.50 2016-12-19 4 M 0 667 0.00 D 2024-11-05 Common Stock 667 116381 D The sale reported in the Form 4 was effected pursuant to a Rule 10b5 1 trading plan adopted by the Reporting Person. The transaction was executed in multiple trades in prices ranging from $27.75 to $28.70, inclusive. The price reported in Column 4 above reflects the weighted average sale price. The Reporting Person hereby undertakes to provide upon request to the SEC staff, the Issuer, or a stockholder of the Issuer, information regarding the number of shares and prices at which the transaction was effected. The underlying shares vest pursuant to the following schedule: Twenty Five Percent (25%) of the shares subject to the option vest one year measured from September 22, 2014 (the "Vesting Commencement Date") and the remaining shares subject to the option vest in 36 successive, equal monthly installments thereafter on each monthly anniversary of the Vesting Commencement Date, subject to Reporting Person's continued service relationship with the Issuer on each such vesting date. /s/ Jean-Frederic Viret 2016-12-20